La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Aehr Test Systems Croissance future

Future contrôle des critères 2/6

Aehr Test Systems devrait augmenter son chiffre d'affaires de 21.2% par an.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Semiconductor croissance des bénéfices	25.7%
Taux de croissance des recettes	21.2%
Rendement futur des capitaux propres	n/a
Couverture par les analystes	Low
Dernière mise à jour	17 Jul 2024

Mises à jour récentes de la croissance future

Recent updates

Aehr Test Systems' (NASDAQ:AEHR) 27% Share Price Surge Not Quite Adding Up

Jul 17

Aehr Test Systems: The Bottom Might Be In

Jun 07

We Like These Underlying Return On Capital Trends At Aehr Test Systems (NASDAQ:AEHR)

Jun 06

Why Aehr Test Systems (NASDAQ:AEHR) Could Be Worth Watching

May 01

Aehr Test Systems' (NASDAQ:AEHR) Solid Earnings May Rest On Weak Foundations

Apr 18

Some Confidence Is Lacking In Aehr Test Systems (NASDAQ:AEHR) As Shares Slide 30%

Apr 01

Investors Shouldn't Overlook Aehr Test Systems' (NASDAQ:AEHR) Impressive Returns On Capital

Feb 21

Here's Why We Think Aehr Test Systems (NASDAQ:AEHR) Might Deserve Your Attention Today

Aug 09

The Return Trends At Aehr Test Systems (NASDAQ:AEHR) Look Promising

Jul 05

Is It Too Late To Consider Buying Aehr Test Systems (NASDAQ:AEHR)?

Jun 17

Investors Interested In Aehr Test Systems' (NASDAQ:AEHR) Earnings

May 16

If EPS Growth Is Important To You, Aehr Test Systems (NASDAQ:AEHR) Presents An Opportunity

Apr 30

Returns On Capital Are Showing Encouraging Signs At Aehr Test Systems (NASDAQ:AEHR)

Apr 03

We Ran A Stock Scan For Earnings Growth And Aehr Test Systems (NASDAQ:AEHR) Passed With Ease

Jan 15

Aehr Test Systems (NASDAQ:AEHR) Is Experiencing Growth In Returns On Capital

Dec 28

Aehr secures orders for multi-wafer test system

Oct 13

Aehr Test Systems Q1 2023 Earnings Preview

Oct 05

Prévisions de croissance des bénéfices et des revenus

NasdaqCM:AEHR - Estimations futures des analystes et données financières antérieures (USD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
5/31/2027	125	N/A	N/A	N/A	1
5/31/2026	92	N/A	N/A	N/A	1
5/31/2025	70	N/A	N/A	N/A	2
5/31/2024	66	33	1	2	N/A
2/29/2024	72	15	5	6	N/A
11/30/2023	82	21	6	8	N/A
8/31/2023	75	19	7	8	N/A
5/31/2023	65	15	9	10	N/A
2/28/2023	63	14	3	3	N/A
11/30/2022	61	12	1	2	N/A
8/31/2022	56	9	5	5	N/A
5/31/2022	51	9	1	2	N/A
2/28/2022	38	4	2	2	N/A
11/30/2021	28	1	5	5	N/A
8/31/2021	20	-1	-2	-1	N/A
5/31/2021	17	-2	-3	-3	N/A
2/28/2021	13	-5	-4	-4	N/A
11/30/2020	14	-4	-4	-4	N/A
8/31/2020	19	-2	-1	-1	N/A
5/31/2020	22	-3	-2	-2	N/A
2/29/2020	26	0	-2	-1	N/A
11/30/2019	23	-3	-3	-3	N/A
8/31/2019	22	-4	-5	-5	N/A
5/31/2019	21	-5	-6	-6	N/A
2/28/2019	21	-5	-3	-3	N/A
11/30/2018	25	-2	-3	-2	N/A
8/31/2018	27	-1	1	2	N/A
5/31/2018	30	1	-2	-1	N/A
2/28/2018	29	0	N/A	-3	N/A
11/30/2017	24	-3	N/A	-5	N/A
8/31/2017	21	-5	N/A	-10	N/A
5/31/2017	19	-6	N/A	-4	N/A
2/28/2017	14	-8	N/A	-6	N/A
11/30/2016	13	-8	N/A	-4	N/A
8/31/2016	13	-8	N/A	-3	N/A
5/31/2016	15	-7	N/A	-6	N/A
2/29/2016	15	-6	N/A	-5	N/A
11/30/2015	15	-4	N/A	-5	N/A
8/31/2015	13	-5	N/A	-4	N/A
5/31/2015	10	-7	N/A	-2	N/A
2/28/2015	14	-5	N/A	-2	N/A
11/30/2014	17	-3	N/A	-2	N/A
8/31/2014	19	0	N/A	-1	N/A
5/31/2014	20	0	N/A	-1	N/A
2/28/2014	18	-1	N/A	0	N/A
11/30/2013	15	-2	N/A	1	N/A
8/31/2013	15	-3	N/A	0	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Données insuffisantes pour déterminer si la croissance des bénéfices prévue de AEHR est supérieure au taux d'épargne ( 2.5% ).

Bénéfices vs marché: Données insuffisantes pour déterminer si les bénéfices de AEHR devraient croître plus rapidement que le marché US

Croissance élevée des bénéfices: Données insuffisantes pour déterminer si les bénéfices de AEHR devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de AEHR ( 21.2% par an) devrait croître plus rapidement que le marché US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de AEHR ( 21.2% par an) devrait croître plus rapidement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de AEHR devrait être élevé dans 3 ans

Aehr Test Systems Croissance future

Future contrôle des critères 2/6

Informations clés

Mises à jour récentes de la croissance future

Price target increased by 108% to US$25.00

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Provides Earnings Guidance for the Year 2024

Aehr Test Systems Reiterates Revenue Guidance for the Fiscal Year Ending May 31, 2023

Recent updates

Investor sentiment deteriorates as stock falls 19%

Independent Director recently sold US$186k worth of stock

Price target increased by 108% to US$25.00

Full year 2024 earnings released: EPS: US$1.15 (vs US$0.52 in FY 2023)

Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1.

Aehr Test Systems' (NASDAQ:AEHR) 27% Share Price Surge Not Quite Adding Up

Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1.

Investor sentiment improves as stock rises 40%

Aehr Test Systems to Report Q4, 2024 Results on Jul 16, 2024

Now 23% overvalued

Investor sentiment deteriorates as stock falls 18%

Now 20% overvalued

New minor risk - Share price stability

Aehr Test Systems: The Bottom Might Be In

We Like These Underlying Return On Capital Trends At Aehr Test Systems (NASDAQ:AEHR)

Investor sentiment improves as stock rises 15%

Insufficient new directors

Why Aehr Test Systems (NASDAQ:AEHR) Could Be Worth Watching

Now 24% overvalued

Aehr Test Systems' (NASDAQ:AEHR) Solid Earnings May Rest On Weak Foundations

New major risk - Revenue and earnings growth

Third quarter 2024 earnings released: US$0.051 loss per share (vs US$0.15 profit in 3Q 2023)

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Some Confidence Is Lacking In Aehr Test Systems (NASDAQ:AEHR) As Shares Slide 30%

Investor sentiment deteriorates as stock falls 15%

Aehr Test Systems to Report Q3, 2024 Results on Apr 09, 2024

Investor sentiment deteriorates as stock falls 16%

Investors Shouldn't Overlook Aehr Test Systems' (NASDAQ:AEHR) Impressive Returns On Capital

Aehr Test Systems Faces Cyclical Headwinds (Rating Downgrade)

Investor sentiment improves as stock rises 17%

Founder & Independent Chairman exercised options to buy US$310k worth of stock.

Should You Investigate Aehr Test Systems (NASDAQ:AEHR) At US$14.85?

President recently sold US$85k worth of stock

President notifies of intention to sell stock

Aehr Test Systems: Revised Guidance Likely To Be Lowered Again - Sell

Second quarter 2024 earnings released: EPS: US$0.21 (vs US$0.14 in 2Q 2023)

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems' (NASDAQ:AEHR) Shareholders Might Be Looking For Exit

Does Aehr Test Systems (NASDAQ:AEHR) Deserve A Spot On Your Watchlist?

Investor sentiment deteriorates as stock falls 22%

Aehr Test Systems Announces Resignation of Rhea J. Posedel from Corporate Governance and Nominating Committee

Investor sentiment deteriorates as stock falls 21%

Aehr Test Systems (NASDAQ:AEHR) Is Very Good At Capital Allocation

First quarter 2024 earnings released: EPS: US$0.16 (vs US$0.022 in 1Q 2023)

Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems to Report Q1, 2024 Results on Oct 05, 2023

Aehr Test Systems, Annual General Meeting, Oct 23, 2023

Calculating The Fair Value Of Aehr Test Systems (NASDAQ:AEHR)

Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)

Investor sentiment deteriorates as stock falls 18%

Here's Why We Think Aehr Test Systems (NASDAQ:AEHR) Might Deserve Your Attention Today

Independent Director notifies of intention to sell stock

Independent Director notifies of intention to sell stock

President recently sold US$6.3m worth of stock

President notifies of intention to sell stock

Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)

Aehr Test Systems Provides Earnings Guidance for the Year 2024

Aehr Test Systems to Report Q4, 2023 Results on Jul 13, 2023

The Return Trends At Aehr Test Systems (NASDAQ:AEHR) Look Promising

Is It Too Late To Consider Buying Aehr Test Systems (NASDAQ:AEHR)?

Investor sentiment improves as stock rises 23%

Aehr Test Systems Appoints Chris Siu as Executive Vice President of Finance and Secretary Effective June 1, 2023

Founder & Chairman notifies of intention to sell stock

Investor sentiment improves as stock rises 15%

Investors Interested In Aehr Test Systems' (NASDAQ:AEHR) Earnings

If EPS Growth Is Important To You, Aehr Test Systems (NASDAQ:AEHR) Presents An Opportunity

Investor sentiment deteriorates as stock falls 21%

Independent Director recently sold US$846k worth of stock

Independent Director exercised options to buy US$551k worth of stock.